For tech, deep-tech, and med-tech startups, your intellectual property (IP) is more than just a legal formality—it is a core business asset. When you seek seed, Series A, or later-stage funding, investors are not just looking at your revenue growth or team structure; they are aggressively auditing the defensibility of your innovation.
Your patent portfolio moves from a necessary expense to a non-negotiable component of valuation.
At Lance IP, we understand that a robust, well-structured patent portfolio is a prerequisite for attracting high-quality institutional investment. Here is a practical guide on how venture capitalists (VCs) and sophisticated angel investors evaluate your patents during due diligence.
The Portfolio Audit: Quality Over Quantity
The first myth to dispel is that investors care about the sheer number of patents. They do not. A stack of irrelevant or weak patents is a liability, signaling wasted money and poor strategy. Investors focus on quality and strategic alignment.
Core Coverage (The “What”)
Investors look for broad claims covering the central, non-obvious breakthrough that defines your company.
- The Question: Does the patent cover the minimum viable product (MVP), or does it cover the future platform? If your patent only covers Version 1.0, the portfolio is weak. Investors want claims that extend to the next 5–10 years of product evolution.
- Actionable Insight: The portfolio must demonstrate that the competition cannot enter the market without infringing your claims, even if they slightly alter their design.
Defensive Gaps (The “Where”)
Investors look for holes in your protection. These gaps represent an open door for competitors.
- Geographic Coverage: Do the patents cover your target markets? For hardware, this means manufacturing hubs (e.g., China). For consumer tech, this means sales markets (e.g., US, EU, Japan). A US-only patent for a globally marketed product is a major red flag.
- Enforceability: They assess the filing history. Were the required maintenance fees paid? Are the claims definite and supported by the specification? (A poorly drafted patent is worthless in court.)
The Business Audit: Market Alignment and Moat
Investors see patents not as legal documents, but as market barriers (moats). They want assurance that the IP creates a sustainable competitive advantage.
- Freedom-to-Operate (FTO)
This is a critical, often neglected, component. Investors need assurance that your product does not infringe on existing, active patents owned by larger competitors.
- The Risk: If you secure funding and scale rapidly, you become a bigger target for an infringement lawsuit from a deep-pocketed incumbent. This risk can immediately kill a deal.
- Investor View: A completed, documented FTO analysis shows professionalism and reduces their downside risk.
Licensing and Monetization Potential
A strong patent can generate revenue independently of product sales.
- Defensive Value: The patent protects your market share.
- Offensive Value: Can you sue or license the patent to others in related industries? If the patent covers a core foundational technology, it represents a potential future revenue stream through licensing, which VCs highly value.
- Relationship to Trade Secrets: Investors check if the company is properly using a hybrid strategy.
- The Question: Is the visible, reverse-engineerable part patented, while the invisible, proprietary data or process (e.g., AI training data, unique chemical formulation steps) is properly secured as a trade secret? This demonstrates strategic resource allocation.
The Prosecution Audit: Process and Strategy
The way your patent was obtained reveals a lot about the legal expertise of your team and your outside counsel.
| Investor Question | What They Are Looking For | Significance |
| Prosecution History | Did the application get a quick grant, or was there significant back-and-forth? | A long, difficult prosecution history suggests the claims were weak or the prior art was too close. |
| Claim Amendments | Were the broad, independent claims drastically narrowed to overcome rejections? | Heavy narrowing means the patent covers a much smaller invention than initially claimed, limiting its commercial value. |
| PCT Usage | Did the company strategically use the PCT to buy time and secure global priority? | This shows planning, cost-consciousness, and a clear vision for global market entry. |
| Inventor Clarity | Is the ownership clear? Are all true inventors listed? | Ambiguity here (e.g., a former consultant claims co-inventorship) creates ownership disputes that can freeze the company and its assets. |
Conclusion: Your Patent Portfolio is a Due Diligence Scorecard
Investors view your patent portfolio as a scorecard for your defensibility and strategic foresight. It signals whether you are building a transient business or a long-term, defensible enterprise. A disorganized, weak, or overly narrow portfolio dramatically lowers the investment valuation and raises the risk profile.
Ensure your patent strategy aligns with your business goals, and treat your IP counsel as a strategic business partner, not just a document filer.